初诊临床FLT3-ITD阴性急性髓系白血病中可检出亚临床微小FLT3-ITD克隆
研究对74例初诊细胞遗传学正常且凝胶电泳未检出FLT3-ITD的急性髓系白血病样本行二代测序,19例检出微小FLT3-ITD。微小FLT3-ITD的分子特征与临床相关FLT3-ITD相似,生存与无可检出FLT3-ITD者相似,但发病后1年内复发率显著更高。随访18例复发样本显示微小FLT3-ITD可扩增为复发时的优势克隆。
要点
- 初诊凝胶电泳FLT3-ITD阴性AML中,二代测序可检出微小FLT3-ITD。
- 微小FLT3-ITD者生存与无可检出FLT3-ITD者相似,但1年内复发率显著更高。
- 微小FLT3-ITD可在复发时扩增为临床相关FLT3-ITD优势克隆。
核心结论
- 初诊临床FLT3-ITD阴性AML中存在亚临床微小FLT3-ITD,其可在复发时扩增为优势克隆。
研究设计与样本
- 选取74例初诊细胞遗传学正常、凝胶电泳未检出FLT3-ITD的急性髓系白血病样本行二代测序。
- 比较临床相关FLT3-ITD组(n=37)、微小FLT3-ITD组(n=19)和无可检出FLT3-ITD组(n=55)。
- 随访18例初诊临床FLT3-ITD阴性患者的复发样本。
主要发现
- 74例中二代测序检出微小FLT3-ITD共19例。
- 微小FLT3-ITD的分子特征(位置和长度)与临床相关FLT3-ITD相似。
- 微小FLT3-ITD组生存与无可检出FLT3-ITD组相似,但发病后1年内复发率显著更高。
- 3例微小FLT3-ITD复发者中2例进展为临床相关FLT3-ITD。
- 15例二代测序未检出FLT3-ITD者中2例复发时出现微小FLT3-ITD,其中1例第二次复发时进展为临床相关FLT3-ITD。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in next-generation sequencing (NGS) have enabled the detection of subclinical minute FLT3-ITD. We selected 74 newly diagnosed, cytogenetically normal acute myeloid leukaemia (AML) samples in which FLT3-ITD was not detected by gel electrophoresis. We sequenced them using NGS and found minute FLT3-ITDs in 19 cases. We compared cases with clinically relevant FLT3-ITD (n = 37), cases with minute FLT3-ITD (n = 19) and cases without detectable FLT3-ITD (n = 55). Molecular characteristics (location and length) of minute FLT3-ITD were similar to those of clinically relevant FLT3-ITD. Survival of cases with minute FLT3-ITD was similar to that of cases without detectable FLT3-ITD, whereas the relapse rate within 1 year after onset was significantly higher in cases with minute FLT3-ITD. We followed 18 relapsed samples of cases with clinically FLT3-ITD-negative at diagnosis. Two of 3 cases with minute FLT3-ITD relapsed with progression to clinically relevant FLT3-ITD. Two of 15 cases in which FLT3-ITD was not detected by NGS relapsed with the emergence of minute FLT3-ITD, and one of them showed progression to clinically relevant FLT3-ITD at the second relapse. We revealed the clonal dynamics of subclinical minute FLT3-ITD in clinically FLT3-ITD-negative AML. Minute FLT3-ITD at the initial AML can expand to become a dominant clone at relapse.
引用
- Yokoyama S, Onozawa M, Yoshida S, et al. Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosis. Br J Haematol. 2023. PMID: 37067758. doi:10.1111/bjh.18800
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。